DEREK RATLIFF: Open Payments
NPI 1861094211 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,928 in 206 payments from 14 companies in 2025. Trend: 2023 $2,119 · 2024 $2,716 · 2025 $6,928
Food & beverage: $3,147Consulting: $2,040Travel & lodging: $976Speaker / faculty: $765
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $4,465 |
| Lundbeck LLC | 23 | $377 |
| E.R. Squibb & Sons, L.L.C. | 25 | $334 |
| Alkermes, Inc. | 15 | $278 |
| Otsuka America Pharmaceutical, Inc. | 14 | $260 |
| Neurocrine BioSciences, Inc. | 15 | $223 |
| Teva Pharmaceuticals USA, Inc. | 17 | $183 |
| Vanda Pharmaceuticals Inc. | 10 | $182 |
| Janssen Pharmaceuticals, Inc | 14 | $179 |
| ABBVIE INC. | 20 | $169 |
Products named: CAPLYTA, COBENFY, ABILIFY ASIMTUFII, REXULTI, ARISTADA, INGREZZA, VRAYLAR, FANAPT.
Industry payments across KY — which companies pay providers there.
